Informação sobre produto
- Sto-609
STO-609 is an orally bioavailable small molecule that inhibits the activity of a key enzyme in the insulin signaling pathway, protein kinase B (PKB). It has been shown to inhibit the growth of new blood vessels and reduce neuronal death. The drug was evaluated in vitro as well as in vivo for potential therapeutic effects on diabetes. In vitro, STO-609 inhibited PKB and suppressed glucose uptake. In vivo, STO-609 significantly lowered blood glucose levels and increased insulin sensitivity in mice with type 2 diabetes. The drug also showed inhibitory properties against a response element that is involved in the angiogenic process. These results suggest that STO-609 may be useful for treating diabetic patients who have not responded to other therapies.
Propriedades químicas
Consulta técnica sobre: 3D-CCA02986 STO-609
Se desejar solicitar um orçamento ou fazer uma encomenda, por favor, adicione os produtos ao seu carrinho e depois solicite um orçamento ou encomenda a partir do carrinho. É mais rápido, mais barato e poderá beneficiar-se dos descontos e outras vantagens disponíveis.
